Also, there was no difference in the proportion of patients with T2D experiencing severe hypoglycaemia after treatment with sulfonylurea compared to insulin [7], while metformin was associated with a lower risk for hypoglycaemia compared with conventional therapy with sulfonylurea or insulin. This evidence concerns the gene INS and Hypoglycemia.